Phillip Peterson
Family Medicine · Princeton, WVNPI 1104882596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$843
- Novo Nordisk$819
- Lilly USA, LLC$732
- Boehringer Ingelheim$536
- Amgen$521
- AstraZeneca$476
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,021100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $843 |
| Novo Nordisk | 47 | $819 |
| Lilly USA, LLC | 44 | $732 |
| Boehringer Ingelheim | 28 | $536 |
| Amgen | 34 | $521 |
| AstraZeneca | 29 | $476 |
| Bayer | 31 | $430 |
| GSK | 30 | $418 |
| Abbott | 12 | $343 |
| Merck | 24 | $320 |
| Mylan Specialty L.p. | 14 | $277 |
| Novartis | 14 | $256 |
| Exact Sciences | 13 | $252 |
| Amarin Pharma, Inc. | 6 | $100 |
| Dexcom, Inc. | 5 | $90 |
| Johnson & Johnson | 3 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Biogen | 4 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 4 | $53 |
| Pfizer | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Vertex | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Vifor Pharma, Inc. | 1 | $15 |
| Corium, LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$136
- VRAYLAR$120
- Repatha$116
How this compares
$7,021 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 12 | $155,958 |
| FarxigaDapagliflozin Propanediol | 138 | $121,267 |
| OzempicSemaglutide | 101 | $108,823 |
| JardianceEmpagliflozin | 72 | $69,517 |
| JanuviaSitagliptin Phosphate | 80 | $65,187 |
| EliquisApixaban | 72 | $57,732 |
| NuplazidPimavanserin Tartrate | 13 | $53,251 |
| KerendiaFinerenone | 49 | $36,258 |
| MounjaroTirzepatide | 24 | $28,682 |
| TradjentaLinagliptin | 37 | $28,390 |
| LinzessLinaclotide | 37 | $21,595 |
| RybelsusSemaglutide | 12 | $12,836 |
| Humalog Kwikpen U-100Insulin Lispro | 39 | $11,011 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 57 | $9,064 |
| InvokanaCanagliflozin | 16 | $9,034 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Jardiance, Tradjenta | $536 | $253,866121 claims |
| AstraZenecaFarxiga, Symbicort | $476 | $127,778156 claims |
| Novo NordiskOzempic, Rybelsus | $819 | $121,658113 claims |
| MerckJanuvia | $320 | $65,18780 claims |
| PfizerEliquis, Premarin | $38 | $61,35283 claims |
| Acadia Pharmaceuticals IncNuplazid | $23 | $53,25113 claims |
| BayerKerendia | $430 | $36,25849 claims |
| Lilly USA, LLCMounjaro | $732 | $28,68224 claims |
| AbbVieLinzess | $843 | $21,59537 claims |
| GSKAnoro Ellipta, Breo Ellipta | $418 | $13,71727 claims |
| Johnson & JohnsonInvokana | $80 | $9,03416 claims |
| Sanofi-aventis U.S. LLCLantus | $32 | $3,68222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Princeton
- Ryan RunyonPrinceton$21K
- Julie DetempleSouth Charleston$129K
- John CornellHuntington$68K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- David HessBridgeport$20K
- Cherry LobatonMartinsburg$19K
- Melissa GamponiaCharleston$18K
- Stephen MascioFollansbee$17K
- Kenneth AdkinsSouth Charleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.